Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 31.
doi: 10.1007/s10096-025-05177-7. Online ahead of print.

Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)

Affiliations

Diagnostic yield of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays on non-pulmonary samples from suspected cases of extra-pulmonary tuberculosis (EPTB)

Anvita Gupta Malhotra et al. Eur J Clin Microbiol Infect Dis. .

Abstract

Background: Extrapulmonary tuberculosis (EPTB) poses a diagnostic challenge due to its paucibacillary nature and low diagnostic yield of traditional methods. Molecular diagnostic tools like Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB offer promising alternatives for the rapid and higher detection rates for pulmonary TB samples. However, the yield of these newly introduced molecular tests on extra-pulmonary samples requires country-specific evaluation and comparative analysis.

Methodology: This study evaluated the diagnostic performance of Xpert MTB/RIF, Xpert MTB/RIF Ultra, and Truenat MTB assays in detecting EPTB on 211 clinical specimens collected at a tertiary care centre of central India. The assays' sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPP) were compared against a composite reference standard.

Results: Xpert MTB/RIF Ultra exhibited the highest sensitivity (50%) for EPTB detection, outperforming the standard GeneXpert MTB/RIF (29.4%) and Truenat MTB (35.3%), with comparable specificity across all three assays. Among the specimen types, pus samples demonstrated the highest (value) diagnostic yield. These findings highlight the superior diagnostic capabilities of Xpert MTB/RIF Ultra, particularly in paucibacillary cases.

Conclusion: Xpert Ultra demonstrates superior sensitivity for EPTB detection compared to Xpert MTB/RIF and Truenat MTB, making it a promising tool to enhance diagnostic accuracy in paucibacillary TB. Its adoption as a standard diagnostic method could significantly improve EPTB management. These findings advocate for integrating advanced molecular diagnostics into routine tuberculosis workflows to reduce diagnostic delays and improve patient outcomes.

Clinical trail number: Not applicable.

Keywords: Diagnostic accuracy; Extrapulmonary tuberculosis (EPTB); Molecular diagnostics; Truenat MTB; Xpert MTB/RIF; Xpert MTB/RIF Ultra.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Similar articles

References

    1. Global Tuberculosis Report (2024) https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa...
    1. Training Module on Extrapulmonary TB– Central Tuberculosis Division https://tbcindia.mohfw.gov.in/2023/06/06/training-module-on-extrapulmona...
    1. Chakravorty S et al (2017) The new Xpert MTB/RIF ultra: improving detection of Mycobacterium tuberculosis and resistance to Rifampin in an assay suitable for Point-of-Care testing. mBio 8. https://doi.org/10.1128/mbio.00812-17
    1. Gomathi NS et al (2020) Multicentric validation of Indigenous molecular test Truenat MTB for detection of Mycobacterium tuberculosis in sputum samples from presumptive pulmonary tuberculosis patients in comparison with reference standards. Indian J Med Res 152:378 - DOI - PubMed - PMC
    1. Chatterjee M, Bhattacharya S, Karak K, Dastidar SG (2013) Effects of different methods of decontamination for successful cultivation of Mycobacterium tuberculosis. Indian J Med Res 138:541–548 - PubMed - PMC

LinkOut - more resources